It's arrived!!Very proud to see the delivery of this super book. This grew from an idea in lockdown with a wonderful collaboration of 56 amazing colleagues who kindly said "Yes!". I wish to thank everyone involved for all their support. So much to learn from every chapter.

NEW: we need to talk about NHS staff retention. At a time when Britain’s healthcare system is acutely short of workers, *1 in 7* UK-trained doctors are practising overseas. No other developed country is like this, which immediately tells you there’s a problem. Let’s dig deeper:

Excellent initiative to train clinicians in ultrasound guided neck node biopsies for the first ENT clinic appt, supporting an earlier and faster diagnosis for patients, whether or not they are diagnosed with head and neck cancer Greater Manchester Cancer Alliance #findoutfaster

On my way - Chicago via London! #asco2023 first time asco, first time Chicago 🙌🇺🇸

David Thomson takes to the stage to present data from NIMRAD at #ASCO2023 Manchester Cancer Research Centre Cancer Research UK James Price Catharine West 🙌 🎉 🎊 #venturingabovethediaphragm #urooncologistoutofwater

At #ASCO23, our Dr. Renata Ferrarotto presented her Phase II trial results of a new immunotherapy and chemotherapy combination for cancer of the larynx. All 23 of the patients on the combination demonstrated good disease control. Learn more: bit.ly/429mZMf #EndCancer

Fantastic achievement for GM research and the @NIHRCRN_gman 👏

The TORPEdO #ClinicalTrial reached its target enrolment of 205 participants this week. Thank you to all participants and colleagues involved in TORPEdO.

Proud as the UKs first proton trial completes recruitment & ahead of schedule too! Many thanks to the patients, and all involved. It’s been a huge team effort! Very grateful to Science and Innovation at Cancer Research UK for funding the trial and RTTQA for their superb work.

Very often in healthcare, we make a massive effort to improve our delivery performance by changing our processes and practices. We should probably start much higher up in our knowledge structure by considering our paradigm - our beliefs about how to make change happen. If we do

Do we need to provide adjuvant radiotherapy for low grade salivary gland cancers? Hard question - requires a large collaborative. Proud of the team from CSOHNS through our Canadian 🇨🇦 Head & Neck Collaborative doi.org/10.1002/cncr.3… with 14 centers !

Some excellent recent papers discussed by the HN editors in this month’s Red Journal oncoscan. Enjoy! Free link here: authors.elsevier.com/a/1hPVL_8CJj1c… Dr. Danielle Margalit Christina Henson, MD Christopher Wilke Lachlan McDowell IJROBP - The Red Journal

So much smearing & belittling of consultants in the press, but this, from today’s The Times and The Sunday Times letters page, could not have put it more beautifully. Pls RT if you agree. #NHS 💙

Another epic story from Tex - thank you for sharing your experience with us! #HeadandNeckCancerAwarenessDay #PPIE David Thomson @AnnaRarity3

Amazing - well done Tex!

Congrats David Thomson James Price Kate Garcez and all involved in getting this over the line. A really important cohort of HNSCC patients with often limited options. Looking forward to opening the EORTC 2120 RAVINA trial here in Galway in 2024. Ye will have to come visit....

Pierre Blanchard, MD I draw something similar, but less anterior. On a node-positive neck in OPC, I just treat the IB nodal tissue anterior to IIA, but not going more anterior than the anterior aspect of the gland. Also feel sparing IB entirely is reasonable (this splits the difference).

John De Almeida David Sher Umamaheswar Duvvuri MD PhD Matthew Ward Karthik Rajasekaran Penn Otorhinolaryngology Penn Medicine Neil D. Gross, MD, FACS Dr. Chris Holsinger Michael Topf MD, MSCI Vin Paleri Katie Van Abel (she/her(s)) Ali Hosni In our prior experience at Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering Radiation Oncology, which included many cases of unknown primaries (and we often did not extensively look for the primary). 30Gy sterilized these supposedly microscopic foci. Ironically if you did find a tiny minute primary that area would

Enjoyed making my debut at #ESTRO2024.. Lots of fun and a great experience presenting work on generalised competing event modelling in oropharynx cancer.. More to come in this area! #rstats #hncsm #radonc Dr. Loren K. Mell David Thomson TTFF

BAD NEWS! -- Xevinapant +cis in HN Phase 3 negative at interim -- cis ineligible study closing down -- not great news for #hncsm #radonc NRG Oncology (h/t Yao Yu) C. Jillian Tsai, MD, PhD Sana Karam, MD, PhD Nancy Lee Henning Willers, MD, FASTRO emdgroup.com/en/news/xevina…